Most Read Articles
18 days ago
Regardless of dosing, nonvitamin K antagonist oral anticoagulants (NOACs) are more effective than warfarin for atrial fibrillation and safer in Asian than in non-Asian populations, a new meta-analysis shows.
5 days ago
Nonalcoholic fatty liver diseases (NAFLD) and serum concentrations of alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT) and alkaline phosphatase (ALP) are independent predictors of incident type 2 diabetes, a new prospective study shows.
4 days ago
There appears to be no evidence supporting associations between physical activity and asthma control level, spirometric measurements and quality of life in children and adolescents with asthma, according to a study from Brazil.
4 days ago
There is a growing number of targeted therapies being approved for use in cancer therapy in the home setting, and this poses a potential risk among family member and caregivers, particularly those of reproductive risk age, a recent study suggests.

Major GI bleeding risk similar between NOACS and conventional anticoagulation

2 months ago

Nonvitamin K antagonist oral anticoagulants (NOACs) appear to pose a risk of major gastrointestinal (GI) bleeding that is similar to that with conventional anticoagulation, according to a systematic review and meta-analysis. On the other hand, dabigatran and rivaroxaban are associated with increased risk of major GI bleeding.

Researchers searched electronic databases for randomized trials evaluating NOACs vs conventional anticoagulants for approved indications. A total of 43 trials were included, yielding a population of 166,289 patients. The main outcome was major GI bleeding, while secondary outcomes were clinically relevant nonmajor bleeding and upper and lower GI bleeding.

Pooled data showed no difference between NOACs and conventional anticoagulants in the risk of major bleeding (1.5 vs 1.3 percent; odds ratio [OR], 0.98; 95 percent CI, 0.80 to 1.21), clinically relevant nonmajor bleeding (0.6 vs 0.6 percent; OR, 0.93; 0.64 to 1.36), upper GI bleeding (1.5 vs 1.6 percent; OR, 0.96; 0.77 to 1.20) or lower GI bleeding (1.0 vs 1.0 percent; OR, 0.88; 0.67 to 1.15).

However, both dabigatran and rivaroxaban were found to have greater odds of major GI bleeding compared with conventional anticoagulation (dabigatran: 2.0 vs 1.4 percent; OR, 1.27; 1.04 to 1.55 and rivaroxaban: 1.7 vs 1.3 percent; OR, 1.40; 1.15 to 1.70). No difference was observed with apixaban (0.6 vs 0.7 percent; OR, 0.81; 0.64 to 1.02) or edoxaban (1.9 vs 1.6; OR, 0.93; 0.78 to 1.11). These subgroup findings did not persist in other sensitivity analyses.

The present data suggest that while NOACs do not differ with conventional anticoagulation in terms of major GI bleeding risk, dabigatran and rivaroxaban may particularly be associated with greater odds of major GI bleeding. In light of this, additional high-quality studies are needed to characterize GI bleeding risk among NOACs, researchers said.

Unlike vitamin K antagonists, NOACs (eg, apixaban, dabigatran, edoxaban and rivaroxaban) are convenient, as they dismiss the need of regular checking of haemostatic parameters. Moreover, NOACs have been shown to reduce the risk of major bleeding, intracranial haemorrhage in particular. GI bleeding is the most frequent cause of major bleeding, attributed to 30 to 40 percent of such events. [Aliment Pharmacol Ther 2015;42:1239–1249]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
18 days ago
Regardless of dosing, nonvitamin K antagonist oral anticoagulants (NOACs) are more effective than warfarin for atrial fibrillation and safer in Asian than in non-Asian populations, a new meta-analysis shows.
5 days ago
Nonalcoholic fatty liver diseases (NAFLD) and serum concentrations of alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT) and alkaline phosphatase (ALP) are independent predictors of incident type 2 diabetes, a new prospective study shows.
4 days ago
There appears to be no evidence supporting associations between physical activity and asthma control level, spirometric measurements and quality of life in children and adolescents with asthma, according to a study from Brazil.
4 days ago
There is a growing number of targeted therapies being approved for use in cancer therapy in the home setting, and this poses a potential risk among family member and caregivers, particularly those of reproductive risk age, a recent study suggests.